A pronounced expression of HIF-1α is linked to an increased risk of death at early stages of various types of malignant tumours, including carcinomas of uterine cervix, esophageal, mammary carcinoma and cerebral oligodendroglioma [12,23-25]. The gene discussed is HIF1A; the disease is cancer.